Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.
Lancet Oncol
; 23(7): 833-835, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35483383
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
2019-nCoV Vaccine mRNA-1273
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Lancet Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Type:
Article
Affiliation country:
Netherlands